Reduction in infarct size by chronic amlodipine treatment in cholesterol-fed rabbits
- 1 May 1998
- journal article
- Published by Elsevier in Atherosclerosis
- Vol. 138 (1) , 163-170
- https://doi.org/10.1016/s0021-9150(98)00019-7
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Suppression of coronary and systemic atherosclerosis progression by the antioxidant membrane stabilizer amlodipine. In vivo ultrasound and post-mortem comparisonAtherosclerosis, 1994
- Effects of amlodipine on myocardial infarction, infarct expansion, and ventricular geometry in the ratAmerican Heart Journal, 1992
- Absence of Hemodynamic Deterioration in the Presence of Amlodipine Following Experimental Myocardial InfarctionJournal of Cardiovascular Pharmacology, 1992
- The efficacy of amlodipine in myocardial ischemiaAmerican Heart Journal, 1989
- IntroductionAmerican Heart Journal, 1989
- Cardioprotective effects of amlodipine in the ischemic-repefused heartThe American Journal of Cardiology, 1989
- Effects of amlodipine on myocardial ischemia-reperfusion injury in dogsThe American Journal of Cardiology, 1989
- Leukocytes and Ischemia-Induced Myocardial InjuryAnnual Review of Pharmacology and Toxicology, 1986
- Effects of Nisoldipine, A New Calcium Antagonist, on Myocardial Infarct Size and Cardiac Dynamics Following Acute Myocardial InfarctionJournal of Cardiovascular Pharmacology, 1985
- Suppression of atherogenesis in cholesterol-fed rabbit treated with nifedipine.Journal of Clinical Investigation, 1981